End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.017 AUD | 0.00% | 0.00% | -15.00% |
Apr. 10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
Feb. 29 | Syntara Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Mannitol
100.0
%
| 7 | 100.0 % | 6 | 100.0 % | -22.37% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 7 | 100.0 % | 6 | 100.0 % | -22.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gary Phillips
CEO | Chief Executive Officer | 62 | 03-03-11 |
Director of Finance/CFO | 67 | 02-11-30 | |
Jana Baskar
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Kristen Morgan
LAW | General Counsel | - | 08-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
CEO | Chief Executive Officer | 62 | 03-03-11 |
Director of Finance/CFO | 67 | 02-11-30 | |
Kathleen Metters
CHM | Chairman | 66 | 17-06-06 |
Hashan de Silva
BRD | Director/Board Member | - | 23-01-15 |
Simon Green
BRD | Director/Board Member | - | 22-12-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 831,006,340 | 819,152,136 ( 98.57 %) | 0 | 98.57 % |
Company contact information
Sector
Sales per Business
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.00% | 13.15M | |
+27.92% | 672B | |
+27.20% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+6.83% | 217B | |
+5.33% | 199B | |
-8.06% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- SNT Stock
- Company Syntara Limited